CRMD
CRMD
NASDAQ · Pharmaceuticals

Cormedix Inc

$8.70
+0.10 (+1.16%)
As of Jun 24, 2:40 PM ET ·
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Buy 11 92%
Hold 1 8%
Sell 0 0%
Price Target
Analyst Price Target +503.4% upside
Low Target $41.99
Average Target $52.50
High Target $66.46
Current Price $8.70
Current
$8.70
Target
$52.50
$41.99 $52.50 avg $66.46
Scenario Analysis
Bear Case
$41.99
382.6%
Low target
Base Case
$52.50
+503.4%
Avg target
Bull Case
$66.46
+663.9%
High target
Risk/Reward
1.7x
Balanced
Price in Context
52-Week High
$17.43
-50.1% from high
52-Week Low
$6.13
+41.9% from low
Target vs 52W High
$52.50
+201.2% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 79% $1,330.33 +19.1%
RDY
Dr. Reddy's Laboratories
Sell 44 50% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +24.3%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +32.1%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +41.0%
BMY
Bristol-Myers Squibb Co
Hold 36 39% $174.50 +217.3%
ZTS
Zoetis Inc
Buy 24 58% $209.87 +168.5%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -33.2%